Stockscreener 앱 받기
36.96
2.52%
-1.12
전일 마감가:
$38.08
열려 있는:
$38.11
하루 거래량:
719.06K
Relative Volume:
0.11
시가총액:
$4.16B
수익:
-
순이익/손실:
$-99.15M
주가수익비율:
-39.74
EPS:
-0.93
순현금흐름:
$-74.25M
1주 성능:
+3.31%
1개월 성능:
+24.90%
6개월 성능:
+26.43%
1년 성능:
-49.07%
1일 변동 폭
$36.96
$38.72
1주일 범위
$34.61
$39.57
52주 변동 폭
$18.92
$79.10
Viking Therapeutics Inc Stock (VKTX) Company Profile
명칭
Viking Therapeutics Inc
전화
858-704-4660
주소
9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA
VKTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VKTX
Viking Therapeutics Inc
|
36.96 | 4.30B | 0 | -99.15M | -74.25M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.50 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.50 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.12 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
828.79 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.35 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-29 | 개시 | Canaccord Genuity | Buy |
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-04-08 | 개시 | Goldman | Neutral |
| 2025-02-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-02-07 | 개시 | Citigroup | Neutral |
| 2024-12-02 | 개시 | Piper Sandler | Overweight |
| 2024-11-22 | 개시 | B. Riley Securities | Buy |
| 2024-11-04 | 재확인 | H.C. Wainwright | Buy |
| 2024-09-11 | 개시 | JP Morgan | Overweight |
| 2024-06-27 | 개시 | Morgan Stanley | Overweight |
| 2024-05-16 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-03-26 | 재확인 | Oppenheimer | Outperform |
| 2024-03-07 | 개시 | Jefferies | Buy |
| 2024-02-28 | 재확인 | Oppenheimer | Outperform |
| 2023-05-31 | 재개 | ROTH MKM | Buy |
| 2023-03-28 | 재확인 | Maxim Group | Buy |
| 2023-03-17 | 개시 | Stifel | Buy |
| 2021-07-29 | 재개 | BTIG Research | Buy |
| 2021-05-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2020-06-05 | 개시 | BMO Capital Markets | Outperform |
| 2020-05-05 | 개시 | Chardan Capital Markets | Buy |
| 2020-05-01 | 개시 | BTIG Research | Buy |
| 2019-07-16 | 개시 | Oppenheimer | Outperform |
| 2019-06-25 | 개시 | Stifel | Buy |
| 2019-03-29 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-03-14 | 재확인 | Maxim Group | Buy |
| 2019-02-22 | 개시 | SVB Leerink | Mkt Perform |
| 2018-12-12 | 개시 | B. Riley FBR | Buy |
| 2018-11-19 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2018-09-18 | 재확인 | H.C. Wainwright | Buy |
| 2018-09-18 | 재확인 | Maxim Group | Buy |
| 2018-09-18 | 재확인 | Raymond James | Outperform |
| 2018-07-20 | 개시 | SunTrust | Buy |
| 2018-06-28 | 개시 | Raymond James | Outperform |
| 2018-06-01 | 재확인 | Laidlaw | Buy |
| 2018-05-31 | 재확인 | Maxim Group | Buy |
| 2018-03-26 | 재개 | H.C. Wainwright | Buy |
| 2017-11-28 | 재확인 | Maxim Group | Buy |
| 2017-11-21 | 개시 | ROTH Capital | Buy |
모두보기
Viking Therapeutics Inc 주식(VKTX)의 최신 뉴스
Signal strength of Viking Therapeutics Inc. stock in tech scannersEntry Point & Smart Investment Allocation Insights - newser.com
Why Viking Therapeutics Inc. stock could see breakout soonJuly 2025 Levels & Real-Time Chart Breakout Alerts - newser.com
Prediction: The Next Eli Lilly Might Already Be Trading Under $50 - AOL.com
Advanced analytics toolkit walkthrough for Viking Therapeutics Inc.2025 Earnings Impact & Step-by-Step Trade Execution Guides - newser.com
How Viking Therapeutics Inc. (1VT) stock reacts to stronger dollarProfit Target & Accurate Intraday Trading Signals - newser.com
Viking Therapeutics, Inc. (NASDAQ:VKTX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Will Viking Therapeutics Inc. stock outperform Dow Jones indexJuly 2025 Levels & Weekly High Momentum Picks - newser.com
Sell Novo Nordisk And Buy Viking Therapeutics (NASDAQ:VKTX) - Seeking Alpha
Can trapped investors hope for a rebound in Viking Therapeutics Inc.July 2025 Trade Ideas & AI Enhanced Execution Alerts - newser.com
My Top Growth Stock to Buy in November - AOL.com
Viking Therapeutics (VKTX): Assessing Valuation After Shares Jump 28% in the Past Month - Yahoo Finance
Is Viking Therapeutics Inc. (1VT) stock undervalued by metricsJuly 2025 Decliners & Long-Term Growth Plans - newser.com
How Viking Therapeutics Inc. (1VT) stock trades after earningsWatch List & Entry Point Confirmation Signals - newser.com
Should You Buy Viking Therapeutics Before Nov. 5? - The Globe and Mail
Should You Buy Viking Therapeutics Before Nov. 5? - The Motley Fool
Viking Therapeutics Stock Powers Toward Best Month Of The Year — Wall Street, Retail Bulls Fired Up On Obesity Drug Promise - Stocktwits
Is Viking Therapeutics Inc. forming a bottoming baseJuly 2025 Catalysts & Low Risk Growth Stock Ideas - newser.com
How hedge fund analytics apply to Viking Therapeutics Inc. stock2025 Winners & Losers & Real-Time Buy Signal Alerts - newser.com
Can Viking Therapeutics Inc. stock hit record highs againMarket Growth Review & Consistent Profit Trading Strategies - newser.com
Why Viking Therapeutics Inc. stock attracts high net worth investors - newser.com
Daymark Wealth Partners LLC Takes $212,000 Position in Viking Therapeutics, Inc. $VKTX - MarketBeat
How Viking Therapeutics Inc. stock trades during market volatilityEarnings Miss & AI Forecast Swing Trade Picks - newser.com
What makes Viking Therapeutics Inc. stock attractive to growth fundsWeekly Risk Report & Free AI Powered Buy and Sell Recommendations - newser.com
Viking Therapeutics (NASDAQ:VKTX) Trading 6.8% HigherShould You Buy? - MarketBeat
Canaccord Genuity Group Initiates Coverage on Viking Therapeutics (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics (VKTX): Assessing Valuation as VK2735 Clinical Updates Fuel Investor Interest - Sahm
Live market analysis of Viking Therapeutics Inc.Portfolio Return Summary & Verified Swing Trading Watchlists - newser.com
Can Viking Therapeutics Inc. (1VT) stock sustain margin levelsEarnings Performance Report & Low Risk Entry Point Tips - newser.com
3 Promising Growth Stocks That Are Down Around 60% From Their Highs - Yahoo Finance
Heatmap analysis for Viking Therapeutics Inc. and competitors2025 Price Action Summary & Community Driven Trade Alerts - newser.com
What drives Viking Therapeutics Inc 1VT stock priceMACD Trading Signals & Exceptional Profit Ideas - earlytimes.in
Viking Therapeutics, Inc. (VKTX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Retail Investors Now Expect Viking Therapeutics To Bag A Deal After Novo Nordisk, Pfizer Engage In A Bidding War For Rival Metsera - Stocktwits
Viking Therapeutics stock rises ahead of obesity drug presentations at medical conferences - Investing.com Canada
Viking Therapeutics Faces Leadership Share Sales Amid Analyst Optimism - AD HOC NEWS
Greg Zante Sells 6,185 Shares of Viking Therapeutics (NASDAQ:VKTX) Stock - MarketBeat
Marianna Mancini Sells 6,185 Shares of Viking Therapeutics (NASDAQ:VKTX) Stock - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) CEO Brian Lian Sells 38,989 Shares - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Director Sells $2,134,200.00 in Stock - MarketBeat
Can Viking Therapeutics (VKTX) Sustain Its Innovation Edge in Obesity Treatments Amid Intensifying Competition? - Sahm
Viking Therapeutics (NASDAQ: VKTX) to present VK2735 data at ObesityWeek and AHA 2025 - Stock Titan
Viking Therapeutics Inc (VKTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.21%
0.74%
자본화:
|
볼륨(24시간):